Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38


Prostaglandin E2 inhibits matrix mineralization by human bone marrow stromal cell-derived osteoblasts via Epac-dependent cAMP signaling.

Mirsaidi A, Tiaden AN, Richards PJ.

Sci Rep. 2017 May 22;7(1):2243. doi: 10.1038/s41598-017-02650-y.


Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice.

Beier EE, Sheu TJ, Resseguie EA, Takahata M, Awad HA, Cory-Slechta DA, Puzas JE.

Bone Res. 2017 May 9;5:17013. doi: 10.1038/boneres.2017.13. eCollection 2017.


Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis.

Fowler TW, Acevedo C, Mazur CM, Hall-Glenn F, Fields AJ, Bale HA, Ritchie RO, Lotz JC, Vail TP, Alliston T.

Sci Rep. 2017 Mar 22;7:44618. doi: 10.1038/srep44618.


Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).

Rimando MG, Wu HH, Liu YA, Lee CW, Kuo SW, Lo YP, Tseng KF, Liu YS, Lee OK.

Sci Rep. 2016 Nov 30;6:37371. doi: 10.1038/srep37371.


Exosomes from Human Synovial-Derived Mesenchymal Stem Cells Prevent Glucocorticoid-Induced Osteonecrosis of the Femoral Head in the Rat.

Guo SC, Tao SC, Yin WJ, Qi X, Sheng JG, Zhang CQ.

Int J Biol Sci. 2016 Oct 17;12(10):1262-1272. eCollection 2016.


A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis.

Mohan G, Lay EY, Berka H, Ringwood L, Kot A, Chen H, Yao W, Lane NE.

Calcif Tissue Int. 2017 Jan;100(1):67-79. doi: 10.1007/s00223-016-0195-6. Epub 2016 Sep 27.


Expression of HCA2 Receptors in Femoral Epiphysis and Metaphysis of Rats with Dexamethasone-Induced Osteoporosis.

Shomali T, Kamalpour M, Fazeli M, Rafati A.

Int J Mol Cell Med. 2016 Spring;5(2):106-13. Epub 2016 Jun 19.


Glucocorticoids Hijack Runx2 to Stimulate Wif1 for Suppression of Osteoblast Growth and Differentiation.

Morimoto E, Li M, Khalid AB, Krum SA, Chimge NO, Frenkel B.

J Cell Physiol. 2017 Jan;232(1):145-53. doi: 10.1002/jcp.25399. Epub 2016 Apr 26.


Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.

Sinha S, Uchibe K, Usami Y, Pacifici M, Iwamoto M.

Bone. 2016 Sep;90:59-68. doi: 10.1016/j.bone.2016.02.008. Epub 2016 Feb 15.


Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.

Yao W, Dai W, Jiang L, Lay EY, Zhong Z, Ritchie RO, Li X, Ke H, Lane NE.

Osteoporos Int. 2016 Jan;27(1):283-294. doi: 10.1007/s00198-015-3308-6. Epub 2015 Sep 18.


Lipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review).

Tian L, Yu X.

Mol Med Rep. 2015 Jul;12(1):783-94. doi: 10.3892/mmr.2015.3472. Epub 2015 Mar 11. Review.


Prevention of glucocorticoid induced bone changes with beta-ecdysone.

Dai W, Jiang L, Lay YA, Chen H, Jin G, Zhang H, Kot A, Ritchie RO, Lane NE, Yao W.

Bone. 2015 May;74:48-57. doi: 10.1016/j.bone.2015.01.001. Epub 2015 Jan 10.


Optical clearing in dense connective tissues to visualize cellular connectivity in situ.

Calve S, Ready A, Huppenbauer C, Main R, Neu CP.

PLoS One. 2015 Jan 12;10(1):e0116662. doi: 10.1371/journal.pone.0116662. eCollection 2015.


Transcriptional dynamics of a conserved gene expression network associated with craniofacial divergence in Arctic charr.

Ahi EP, Kapralova KH, Pálsson A, Maier VH, Gudbrandsson J, Snorrason SS, Jónsson ZO, Franzdóttir SR.

Evodevo. 2014 Nov 3;5(1):40. doi: 10.1186/2041-9139-5-40. eCollection 2014.


Instructions for producing a mouse model of glucocorticoid-induced osteoporosis.

Thiele S, Baschant U, Rauch A, Rauner M.

Bonekey Rep. 2014 Jul 2;3:552. doi: 10.1038/bonekey.2014.47. eCollection 2014.


Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ.

Cheng Q, Morand E, Yang YH.

Front Pharmacol. 2014 Jul 17;5:169. doi: 10.3389/fphar.2014.00169. eCollection 2014. Review.


Role of glucocorticoid-induced leucine zipper (GILZ) in bone acquisition.

Pan G, Cao J, Yang N, Ding K, Fan C, Xiong WC, Hamrick M, Isales CM, Shi XM.

J Biol Chem. 2014 Jul 11;289(28):19373-82. doi: 10.1074/jbc.M113.535237. Epub 2014 May 23.


Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation.

Li J, Zhang N, Huang X, Xu J, Fernandes JC, Dai K, Zhang X.

Cell Death Dis. 2013 Oct 3;4:e832. doi: 10.1038/cddis.2013.348.


A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.

Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H.

Allergy Asthma Clin Immunol. 2013 Aug 15;9(1):30. doi: 10.1186/1710-1492-9-30.


Supplemental Content

Support Center